home / stock / rexn / rexn quote
Last: | $ |
---|---|
Change Percent: | -9.02% |
Open: | $3.12 |
Close: | $3.33 |
High: | $3.60 |
Low: | $2.99 |
Volume: | 3,197,318 |
Last Trade Date Time: | 02/12/2020 04:42:01 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $3.12 | $3.33 | $3.60 | $2.99 | 3,197,318 | 02-12-2020 |
$ | $2.43 | $3.66 | $4.26 | $2.20 | 20,117,418 | 02-11-2020 |
$ | $2.0443 | $2.0412 | $2.10 | $2.03 | 14,069 | 02-10-2020 |
$ | $2.01 | $2.02 | $2.064 | $2.01 | 11,227 | 02-07-2020 |
$ | $2.06 | $2.01 | $2.10 | $2.0003 | 18,604 | 02-06-2020 |
$ | $2.03 | $2.08 | $2.1355 | $2.02 | 4,692 | 02-05-2020 |
$ | $2.16 | $2.09 | $2.16 | $2.065 | 15,166 | 02-04-2020 |
$ | $2.0263 | $2.16 | $2.17 | $1.99 | 24,578 | 02-03-2020 |
$ | $2.01 | $2.05 | $2.09 | $2.01 | 7,635 | 01-31-2020 |
$ | $2.1729 | $2.0293 | $2.1729 | $2.02 | 16,247 | 01-30-2020 |
$ | $2.2165 | $2.1137 | $2.24 | $2.10 | 7,050 | 01-29-2020 |
$ | $2.1222 | $2.1302 | $2.23 | $2.10 | 22,915 | 01-28-2020 |
$ | $2.10 | $2.07 | $2.17 | $2.07 | 9,649 | 01-27-2020 |
$ | $2.1045 | $2.13 | $2.1628 | $2.0804 | 9,589 | 01-24-2020 |
$ | $2.22 | $2.12 | $2.24 | $2.12 | 18,699 | 01-23-2020 |
$ | $2.30 | $2.25 | $2.3109 | $2.215 | 27,012 | 01-22-2020 |
$ | $2.26 | $2.30 | $2.32 | $2.1907 | 58,583 | 01-21-2020 |
$ | $2.32 | $2.31 | $2.37 | $2.27 | 46,103 | 01-20-2020 |
$ | $2.32 | $2.31 | $2.37 | $2.27 | 45,833 | 01-17-2020 |
$ | $2.32 | $2.27 | $2.3382 | $2.1779 | 27,389 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...